Pleural Effusion — Transudates and Exudates

Net fluid movement = K[(Pc - Pi) - σ(πc - πi)]

Key mechanism 1: Transudative effusions—alteration of systemic hydrostatic or oncotic pressure without pleural pathology

Key mechanism 2: Exudative effusions—increased pleural permeability and inflammatory response

Key mechanism 3: Lymphatic obstruction and malabsorption of pleural fluid

Key mechanism 4: Osmotic gradient and direct fluid transudation from extrapulmonary sources

Transudative Effusions (caused by systemic derangements, not pleural disease)

• Congestive heart failure (50% of all pleural effusions): The single most common cause in clinical practice; typically bilateral (right > left due to anatomy), exacerbated by acute decompensation, diuretic therapy interruption, or new arrhythmias; effusions are usually right-sided or bilateral because the right heart failure component increases right atrial pressure preferentially affecting the lower-lobe pulmonary veins; responds dramatically to diuretics and afterload reduction

• Hepatic cirrhosis with ascites (5-10% of effusions): Occurs almost exclusively in the presence of significant ascites; mechanism combines portal hypertension, splanchnic vasodilation, severe hypoalbuminemia, and sodium retention; typically right-sided and often massive; risk increases with decompensated disease

• Nephrotic syndrome (protein-losing nephropathy): Massive proteinuria (>3.5 g/day) with urinary albumin loss leading to serum albumin <2 g/dL; pleural effusion occurs in approximately 5-10% of nephrotic patients; often bilateral and associated with significant dyspnea; usually improves with immunosuppressive therapy targeting the underlying nephropathy

• Renal failure (acute and chronic): Fluid overload with uremia and reduced albumin synthesis; often multifactorial if concurrent CHF present; diuresis and dialytic fluid removal are therapeutic

• Myxedema: Hypothyroidism causes decreased cardiac output, increased capillary permeability, and protein malnutrition; rare but classic presentation with pericardial effusion also present

• Pulmonary embolism (PE): While often produces exudative effusions, can present as transudative; occurs in approximately 10% of PE cases; effusions are usually small to moderate, unilateral, and may develop over days

• Peritoneal dialysis: Transdiaphragmatic fluid transfer through patent pleuroperitoneal communication or diaphragmatic defect; typically right-sided with high glucose reflecting dialysate osmolarity; diagnosis confirmed by peritoneal dialysate appearance in pleural fluid

Exudative Effusions (caused by pleural or adjacent organ inflammation/infiltration)

• Parapneumonic effusion: Occurs in 20-40% of bacterial pneumonia cases; includes uncomplicated parapneumonic effusion (sterile, responsive to antibiotics alone) and complicated parapneumonic effusion (pH <7.2, low glucose) that may progress to empyema (presence of bacteria in pleural fluid on culture); gram-positive cocci (S. aureus, S. pneumoniae) and gram-negative organisms most common; requires thoracentesis for diagnosis and may necessitate chest tube drainage

• Malignant effusion (25-30% of exudative effusions): Most commonly from lung cancer (40%), breast cancer (20%), lymphoma (20%), and gastric/ovarian malignancies; represents stage IV disease with median survival typically 2-4 months if not receiving systemic therapy; diagnosis by pleural fluid cytology (sensitivity 40-50%, improves with repeated taps) or pleural biopsy; presence of malignant cells in pleural fluid constitutes M1a disease category in staging

• Tuberculosis (TB): Responsible for >50% of exudative effusions in endemic areas; typically develops 3-6 months after primary TB infection; classic lymphocytic exudate with markedly elevated protein, very low glucose (<30 mg/dL, often <20), elevated LDH, and acid-fast bacillus (AFB) culture positive in only 10-15% despite high diagnostic suspicion; pleural biopsy with caseating granulomas (positive in 60-80%) is gold standard; TB PCR assay becoming standard for rapid diagnosis

• Pulmonary embolism (PE): Occurs in 10% of PE cases; typically produces small to moderate, unilateral, hemorrhagic or non-hemorrhagic exudate; mechanism involves both increased permeability (from ischemic infarction and inflammation) and possibly transient lymphatic obstruction; diagnosis should be considered in any exudative effusion with unexplained dyspnea or pleuritic chest pain; approximately 30% have associated pleural effusion on imaging

• Viral pleuritis: Common causes include influenza, COVID-19, coxsackievirus, and adenovirus; exudative effusion with lymphocytic predominance; typically self-limited, resolving within 2-4 weeks; diagnosis is largely clinical, with viral cultures rarely performed on pleural fluid; elevated LDH and protein differentiate from transudates

• Rheumatologic diseases (SLE, rheumatoid arthritis): SLE produces effusion in 5% of cases with characteristically very low complement levels (C3, C4) in pleural fluid relative to serum, elevated LDH, and presence of LE cells; rheumatoid arthritis causes cholesterol-rich exudate (appearing golden/turbid) with very low glucose (<20 mg/dL, matching TB) and low pH; Sjogren's syndrome and other connective tissue diseases less common

• Esophageal rupture (Boerhaave syndrome): Spontaneous or iatrogenic (post-endoscopy, post-dilation); presents with acute mediastinitis and rapidly progressive exudative effusion; pleural fluid with elevated amylase (>serum level) and elevated salivary enzymes; diagnosis by esophagography (water-soluble contrast) or CT; mortality >30% if diagnosis delayed >24 hours; requires urgent surgical intervention

• Acute pancreatitis: Exudative effusion with elevated pleural amylase (higher than serum), typically left-sided or bilateral; incidence 5-10% in acute pancreatitis; mechanism involves transdiaphragmatic lymphatic inflammation; usually transient, improving with pancreatic inflammation resolution; amylase measurement on pleural fluid aids diagnosis when clinical suspicion high

• Pneumonia with complicated parapneumonic effusion: As above; higher risk with S. aureus, S. pneumoniae, and gram-negative organisms; empyema formation indicated by positive cultures, pH <7.2, glucose <40, LDH >1000

• Hemothorax: Blood in pleural space from trauma, anticoagulation, bleeding diathesis, or spontaneous hemopneumothorax; appears hemorrhagic with RBC count matching or exceeding serum; hematocrit may be 50% of serum; drainage often required if significant (>500 mL)

• Fungal infections (histoplasmosis, coccidioidomycosis, blastomycosis): Geographic distribution limits frequency; exudative with lymphocytic predominance; diagnosis by fungal culture (slow growth), complement fixation serology, or antigen detection

• Drug-induced effusions: Nitrofurantoin, dantrolene sodium, methotrexate, and other agents; presentation variable; require temporal relationship to drug initiation and exclusion of other etiologies

• Post-cardiac surgery effusion: Common occurrence in first 2-4 weeks post-op; usually exudative but may have high cholesterol content; majority small and self-limited; large or symptomatic effusions may require drainage; if hemorrhagic and expanding acutely, concerning for surgical site bleeding

• Radiation pneumonitis: Develops weeks to months after radiation therapy to chest; exudative effusion with lymphocytic predominance; associated with parenchymal changes on imaging; improves with corticosteroids and radiotherapy completion

Cardinal Symptoms

• Dyspnea: The most common presenting symptom, occurring in 75-80% of symptomatic patients with effusion; mechanism involves mechanical restriction of lung expansion, decreased lung compliance from fluid accumulation, and upward displacement of the diaphragm reducing functional residual capacity; severity correlates imperfectly with effusion size, as some large effusions remain asymptomatic while smaller ones cause significant dyspnea; exertional dyspnea typically precedes dyspnea at rest unless effusion large (>500 mL); physiologic mechanisms include increased work of breathing, ventilation-perfusion mismatch from compression atelectasis, and reflex airway response to pleural irritation

• Pleuritic chest pain: Occurs in 10-25% of patients, suggesting acute pleural inflammation (parapneumonic, viral, PE, TB pleuritis); typically sharp, worse with deep breathing or cough, relieved by splinting; indicates visceral or parietal pleural involvement rather than transudative process alone; most common in tuberculosis, rheumatologic diseases, and PE; absence does not exclude serious etiology

• Cough: Present in 20-30%, often non-productive; may result from compression of adjacent airways or irritation from underlying pneumonia; productive cough suggests underlying pneumonia or bronchitis

• Orthopnea and paroxysmal nocturnal dyspnea (PND): Suggest CHF as underlying cause; develop as effusion accumulates and gravity-dependent positioning worsens ventilation in recumbent position; relief with sitting upright is classic

Physical Examination Findings

• Diminished breath sounds and dullness to percussion: Classic findings; occur at the base of effusion, particularly posteriorly (since effusions gravitate to dependent portions); sensitivity increases with effusion size (poor sensitivity for effusions <250 mL); tactile fremitus may be diminished above the effusion level; E→A egophony absent below fluid level

• Pleural friction rub: Rare finding heard near the area of pleural inflammation; grating sound heard during both inspiration and expiration; suggests parapneumonic effusion, viral pleuritis, or PE; often disappears as fluid accumulates between inflamed surfaces

• Elevated hemidiaphragm: Best appreciated on fluoroscopy (ult

Step 1 — imaging

• Upright PA and lateral chest radiograph: first test. Blunting of the posterior costophrenic sulcus on lateral film appears with the smallest volumes; blunting of the lateral costophrenic angle on PA requires substantially more fluid. A meniscus sign indicates free-flowing fluid; complete opacification with contralateral mediastinal shift suggests a massive effusion (think malignancy), whereas ipsilateral shift suggests trapped lung or bronchial obstruction.
• Lateral decubitus film or bedside ultrasound: distinguishes free-flowing from loculated fluid. Ultrasound is preferred in current US practice — it detects small volumes, identifies septations, and, per ACR Appropriateness Criteria and ATS recommendations, real-time ultrasound guidance for thoracentesis reduces pneumothorax and organ injury.
• Contrast CT chest: reserved for suspected empyema (split pleura sign, enhancing thickened pleura) or malignancy (nodular, circumferential, or mediastinal pleural thickening).

Step 2 — diagnostic thoracentesis (the confirmatory test)

• Indicated for any effusion of unknown cause, or one with >1 cm of layering fluid on lateral decubitus radiograph or ultrasound. Bilateral effusions with a classic decompensated heart failure picture may be treated with diuresis first and tapped only if atypical or non-resolving.
• Send protein, LDH, glucose, cell count with differential, Gram stain and culture, and cytology; pH must go in a heparinized syringe analyzed on a blood gas machine.

Step 3 — apply Light's criteria

• Exudate if any one is met: pleural/serum protein >0.5; pleural/serum LDH >0.6; pleural LDH greater than two-thirds the upper limit of normal serum LDH.
• Highly sensitive but over-calls exudate in diuresed heart failure. If the clinical picture says transudate, use the serum-to-pleural albumin gradient (>1.2 g/dL) or serum-to-pleural protein gradient (>3.1 g/dL) to reclassify.

Immediate stabilization

• Large symptomatic effusion with hypoxemia: supplemental oxygen and prompt therapeutic thoracentesis. Remove no more than roughly 1.5 L in a single session, or stop earlier for chest tightness or cough, to avoid re-expansion pulmonary edema.
• Frank pus, sepsis, or suspected esophageal rupture: these are emergencies requiring immediate drainage and, for rupture, urgent surgical consultation.

Transudates — treat the driver, not the pleura

• Loop diuretics (furosemide) plus the four-pillar regimen for HFrEF — ARNI or ACEI/ARB, beta blocker, MRA, and SGLT2 inhibitor — per the ACC/AHA/HFSA heart failure guideline; effusions typically resolve with decongestion.
• Hepatic hydrothorax: sodium restriction and diuretics, then TIPS or transplant evaluation per AASLD guidance. Chest tubes are essentially contraindicated — they cause protein/fluid depletion, infection, and renal failure.
• Nephrotic syndrome/renal failure: treat proteinuria and volume overload; ultrafiltration if dialysis-dependent.

Parapneumonic effusion and empyema

• Antibiotics first — per the IDSA/ATS community-acquired pneumonia guideline. Anaerobic coverage is not routinely added for suspected aspiration pneumonia per IDSA/ATS 2019; add it when lung abscess or empyema is present or suspected.
• Uncomplicated (free-flowing, pH >7.2, normal glucose): antibiotics alone.
• Complicated (pH <7.2, glucose <60 mg/dL, LDH markedly elevated, loculation) or empyema (pus, positive Gram stain/culture): tube thoracostomy. Failure to clear warrants intrapleural fibrinolytic plus DNase (alteplase with dornase alfa) or VATS decortication, an approach reflected in AATS empyema guidance.

Complications of the effusion itself

• Empyema and pleural sepsis (emergency): bacterial proliferation in loculated fluid; signaled by frank pus, pH <7.2, glucose <60 mg/dL, positive Gram stain, and persistent fever despite appropriate antibiotics. Delayed drainage drives mortality.
• Fibrothorax and trapped lung: organizing fibrin forms a restrictive visceral pleural peel; suspect when the lung fails to re-expand after drainage, pleural pressure drops steeply during aspiration, or a pneumothorax ex vacuo appears on the post-tap film. Causes a restrictive pattern on PFTs and may require decortication.
• Acute respiratory failure (emergency): massive effusion compressing lung with atelectasis and shunt physiology; hypoxemia refractory to oxygen mandates urgent drainage.
• Malnutrition and immunodeficiency: from chronic high-output chylothorax (loss of fat, protein, and lymphocytes).

Complications of thoracentesis and drainage

• Pneumothorax: needle laceration of visceral pleura or air entry; signaled by worsening dyspnea and absent breath sounds post-procedure. Risk is reduced substantially with ultrasound guidance. Tension pneumothorax — hypotension, tracheal deviation, distended neck veins — is an emergency requiring immediate needle decompression before imaging.
• Re-expansion pulmonary edema (emergency): rapid removal of a large, chronic effusion generates markedly negative pleural pressure and reperfusion injury of chronically collapsed lung; presents within hours as cough, frothy sputum, hypoxemia, and ipsilateral infiltrates. Prevented by limiting volume removed and stopping for chest discomfort.
• Hemothorax: laceration of the intercostal artery, which is tortuous and unprotected in elderly patients — enter over the superior margin of the rib, and only within the mid-scapular to posterior axillary line. Signaled by falling hematocrit and rapid re-accumulation.
• Organ injury: liver or splenic puncture if the needle is placed below the ninth rib or without ultrasound.
• Catheter-related: indwelling pleural catheter infection or cellulitis; chest tube malposition.
• Talc pleurodesis: fever and pleuritic pain are expected; rarely ARDS/acute pneumonitis, particularly with ungraded small-particle talc; graded large-particle talc is preferred.

• Light's criteria — the single most tested rule: pleural/serum protein >0.5, pleural/serum LDH >0.6, or pleural LDH >2/3 the upper limit of normal serum LDH. Any one positive makes it an exudate. The criteria are deliberately sensitive, so exudate is over-called.
• The classic distractor: a diuresed heart failure patient whose fluid meets Light's criteria by a hair. Do not chase malignancy — calculate the serum-to-pleural albumin gradient; a gradient >1.2 g/dL reclassifies it as a transudate.
• Best next step for a new unilateral effusion of unknown cause is ultrasound-guided diagnostic thoracentesis. Bilateral effusions with an otherwise textbook CHF picture are an exception — diurese first.
• Very low pleural glucose narrows fast: rheumatoid arthritis (the lowest, with low complement and cholesterol-rich, turbid fluid), empyema, tuberculosis, malignancy, and lupus. RA versus TB glucose overlap is a favorite trap; RA fluid also carries a very low pH.
• pH <7.2 in a parapneumonic effusion is the drainage threshold — chest tube, not more antibiotics. Send pH in a heparinized syringe on a blood gas analyzer, never on a urine dipstick.
• Milky fluid: triglycerides >110 mg/dL = chylothorax (thoracic duct injury, lymphoma). Cholesterol crystals with normal triglycerides = pseudochylothorax from chronic RA or TB effusion.
• Elevated pleural amylase: pancreatitis (usually left-sided), esophageal rupture (Boerhaave, salivary amylase, high mortality if missed), and adenocarcinoma.
• Lymphocyte-predominant exudate with high adenosine deaminase = tuberculous pleuritis; AFB smear and culture are frequently negative, so a negative smear does not exclude it.
• Named associations examiners love: Meigs syndrome (benign ovarian fibroma + ascites + right pleural effusion, resolves after tumor resection) and yellow nail syndrome (lymphedema, dystrophic nails, chronic effusion).
• Trapped lung — if the lung will not re-expand, talc pleurodesis will fail; choose an indwelling pleural catheter (ATS/STS/STR).